RENEW · Hormone and cellular care
SS-31 Injection
Mitochondrial science in perspective.
SS-31 is another name used for elamipretide. Learn how its specific clinical context differs from broad wellness claims.
Prescription required. Provider evaluation determines eligibility.
Elamipretide is a peptide that targets mitochondrial cardiolipin. FDA-approved Forzinity has a specific indication for improving muscle strength in patients with Barth syndrome weighing at least 30 kg.
Mitochondria contribute to cellular energy production. A mechanism involving mitochondria does not establish an energy boost, longevity benefit or general performance benefit.
Instructions depend on whether the product is branded Forzinity or another preparation. Do not transfer branded dosing instructions to a compounded formulation.
A discussion must begin with the exact product, clinical reason, evidence, kidney function and relevant risks.
Know the identity.
No borrowed claims.
Elamipretide is a peptide that targets mitochondrial cardiolipin. FDA-approved Forzinity has a specific indication for improving muscle strength in patients with Barth syndrome weighing at least 30 kg.
-
Know the identity
SS-31 refers to elamipretide.
-
A narrow approval
Forzinity’s indication concerns Barth syndrome.
-
No borrowed claims
Approval does not cover a separate compounded product.
Care starts with
understanding you.
A treatment decision should take your health history, current medications and goals into account. Your evaluation is the place to discuss questions, potential risks and whether another approach may be more appropriate.
-
Your health in context
Share your medical history, current medications and treatment goals.
-
A considered decision
Discuss the evidence, potential risks and available alternatives.
-
Clear next steps
If treatment is prescribed, follow the instructions for your exact medication and ask how follow-up will work.
Explore your options
with context.
Different treatments have different uses, risks and levels of evidence. Explore this care category, then discuss the options that may fit your clinical needs.
Explore hormone and cellular care-
Kisspeptin Injection
Kisspeptin acts within the reproductive hormone axis.
Kisspeptin refers to a family of peptides involved in the reproductive hormone axis. The exact peptide form in a formulation matters.
Learn more -
Epithalon Injection
Epithalon and epitalon refer to the same commonly used name.
Epithalon, also spelled epitalon, is a synthetic tetrapeptide. It should not be confused with every pineal-derived peptide preparation.
Learn more -
GHK-Cu/Epithalon Injection
Copper peptide and epithalon in one formulation.
GHK-Cu is a copper-binding peptide; epithalon is a synthetic tetrapeptide. A combination formulation is distinct from either component alone.
Learn more
A plan begins with
an evaluation.
Completing an assessment does not guarantee a prescription.
-
Share your history
Provide information about your health, medications and goals.
-
Review the options
A licensed provider evaluates whether treatment is clinically appropriate. Further information, testing or another type of care may be needed.
-
Understand your prescription
If prescribed, review the medication, administration directions, risks and follow-up plan before starting.
-
Revisit the plan
Discuss your response and any concerns with your prescriber. Do not change a dose or combine treatments on your own.
Know the important
information.
Every medication has potential risks. Review the complete safety information for the exact product and tell your provider about your medical conditions, allergies, pregnancy or pregnancy plans, and all medicines and supplements you take.
Compounded medications are not FDA-approved. FDA does not evaluate these preparations for safety, effectiveness or quality before marketing.
Human safety data may be incomplete. Ingredient identity, purity, formulation and administration route matter; an ingredient’s research history does not establish the safety of a blend.
Seek emergency care for trouble breathing or swelling of the face, lips or throat. Contact a clinician promptly for severe or concerning symptoms. Do not rely on routine online messaging for an emergency.
Frequently asked questions
Forzinity is approved for a specific Barth syndrome indication. That does not approve every SS-31 preparation or wellness use.
A general energy benefit is not established by the approved indication.
No. These are different peptides with different research and regulatory histories.
A licensed provider considers your health history, current medications, clinical needs and the evidence for the specific treatment. Further testing or a different type of care may be recommended.
No. A prescription is provided only when the evaluating provider determines that treatment is medically appropriate and available.
Follow your prescriber and pharmacy's instructions for the exact product. Ask before changing a dose, switching formulations or combining treatments.
Your next step starts with your
health.
Share your history and goals so a licensed provider can evaluate which care options may be appropriate for you.
Prescription required. Treatment is not appropriate for everyone. Assessment does not guarantee a prescription.